Comparative profiling of white matter development in the human and mouse brain reveals volumetric deficits and delayed myelination in Angelman syndrome

This study reveals WM deficits as a hallmark in children with AS, demonstrating for the first time that these deficits are already apparent at 1 year of age. Parallel studies in a mouse model of AS show these deficits occur alongside the delayed onset of myelination, which results from the loss of neuronal (but not glial) UBE3A, though the causal relationship between these phenotypes remains to be determined. These findings emphasize the potential of WM as both a therapeutic target for interventions and a valuable biomarker for tracking the progression of AS and the effectiveness of potential treatments.

Authors

Institutions

Publication Details

Journal
Molecular Autism
Published
2024-12-26
DOI
https://doi.org/10.1186/s13229-024-00636-y
Citations
4
Primary Topic
Genetic Syndromes and Imprinting
Type
article
Field-Weighted Citation Impact
2.20

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative profiling of white matter development in the human and mouse brain reveals volumetric deficits and delayed myelination in Angelman syndrome

A Burette, Li‐Ming Hsu, Mark D. Shen, Sung-Ho Lee et al.
4 citations
Molecular Autism
Genetic Syndromes and Imprinting
2.20
article

Comparative profiling of white matter development in the human and mouse brain reveals volumetric deficits and delayed myelination in Angelman syndrome

A Burette, Li‐Ming Hsu, Mark D. Shen, Sung-Ho Lee, Audrey L. Smith, Benjamin D. Philpot, Heather C. Hazlett, Martin Styner, Yen‐Yu Ian Shih, Siddhi Ozarkar, Ridthi Kartik Rekha Patel, Tasmai Vulli
article en
4 citations

Abstract

This study reveals WM deficits as a hallmark in children with AS, demonstrating for the first time that these deficits are already apparent at 1 year of age. Parallel studies in a mouse model of AS show these deficits occur alongside the delayed onset of myelination, which results from the loss of neuronal (but not glial) UBE3A, though the causal relationship between these phenotypes remains to be determined. These findings emphasize the potential of WM as both a therapeutic target for interventions and a valuable biomarker for tracking the progression of AS and the effectiveness of potential treatments.

Molecular AutismVol. 15(1)
University of North Carolina at Chapel Hill (US), University of North Carolina Health Care (US), Imaging Center (US)
Angelman Syndrome Foundation, Simons Foundation Autism Research Initiative, National Institutes of Health, National Institute of Mental Health, National Institute of Neurological Disorders and Stroke, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Openalex Percentile: Top 11%
Genetic Syndromes and Imprinting
2.20
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.